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Abstract Oncoplastic surgery is integral to all breast cancer
surgeries. The use of an aesthetic approach to breast conserva-
tion or mastectomy greatly enhances the range of options that
can be offered towomenwith breast cancer and facilitates better
outomes from it. It should be the standard of care. However, a
structured approach to selecting appropriate techniques is es-
sential, and although many operative procedures are reported,
this article sets out to describe a set of principles and an algo-
rithm by which the what, when and for whom for oncoplastic
surgery can be defined.
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Introduction
Oncoplastic breast surgery was a term originally coined in the
1980s to reflect the integration of chemotherapy and radio-
therapy planning with conservative forms of breast surgery
for more advanced disease. Its aim was to achieve better aes-
thetic and quality of life outcomes compared to traditional
approaches with less morbidity. The origins were therefore
multidisciplinary, and early developments in oncoplastic sur-
gery served to show that even in locally advanced disease,
obvious deformity was avoidable [1]. The term is now used
ubiquitously to represent any surgery that aims to maintain
quality of life and an acceptable breast appearance whilst at
the same time being uncompromising on oncological effec-
tiveness. Obviously, the latter always remains the primary
goal, but attention to the consequences of surgical treatment,
both short and long term, not just the effectiveness of it, rightly
parallels advances in breast cancer survival. In other words,
oncoplastic surgery is surgery that is considerate to what we
leave women to live with for the rest of their lives and should
be an integral part of treatment for all women with breast
cancer. Breast cancer has so many negative connotations and
insults to a woman’s sense of being whole that it seems star-
tlingly obvious that if the negative impact of surgery can be
reasonably mitigated then it should.
Obviously, the first major step towards offering greater
choice in the aesthetic outcome of breast cancer surgery was
the widespread use of breast-conserving surgery and avoid-
ance of mastectomy where appropriate. Offering even greater
choice of operative procedure in this regard and expanding the
indications for breast conservation as well as improving the
outcomes of it are key aims of oncoplastic surgery. Many
techniques of oncoplastic breast-conserving surgery have
been described, but in general their evolution has followed
three main paths: the use of breast reduction techniques, ini-
tially to remove cancers that were located in areas of the breast
that could be removed as part of a standard reduction tech-
nique but later to include the use of modified techniques to
allow resection of any part of the breast; the use of volume
replacement techniques, initially using variations on LD flaps
but later local perforator-based flaps; and the use of various
techniques to allow en bloc closure of breast defects, from
simple patterns of skin reduction to modifications of cosmetic
mastopexies [2–8]. However, oncoplastic breast surgery is not
just about breast conservation. Applying oncoplastic princi-
ples to mastectomy and reconstruction is just as important.
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The ability to perform an oncoplastic mastectomy is a basic
requirement of any oncoplastic surgeon, whether they be
breast oncology or plastics based. Understanding and apply-
ing the range of mastectomy techniques available and how
they best apply to different oncological and reconstruction
options will give the best potential outcomes.
Essentially, all breast cancer surgery needs to be viewed as
oncoplastic. Here, the politics of breast cancer surgery service
delivery has provided strong headwinds hindering many. This
article does not intend to address these issues but suffice them to
say that essentially, they need to be questioned why anyone
with a general surgery background without aesthetic skills
would operate on the breast and why anyone with a plastic
surgery background without oncologic skills or knowledge
would operate on a breast cancer patient. Having said that,
breast surgery will always require a mixture of oncological,
plastic, and microsurgery skills provided by a team of special-
ists, and the ability to provide this team with the ideal skill base
may be aspirational rather than possible in many parts of the
world. The point is more that ideally any surgeon performing
breast cancer-related surgery requires a minimum skill set, and
this has to include knowledge of all and ability in many of the
techniques that used to reside solely in the parent specialties of
general surgical oncology or plastic surgery.
Therefore, even the traditional simplemastectomy needs to be
performed with thought and planning. The use of contralateral
breast reduction with unilateral simple mastectomy in extremely
ptotic or large-breasted patients has nothing to do with recon-
struction but everything to do with an oncoplastic approach and
quality of life. Creating low-lying scars, flat surfaces for prosthe-
sis and avoiding dog-ears will improve outcomes even without
reconstruction. Different skin and nipple-sparing mastectomy
techniques can be selected depending upon patient morphology,
breast ptosis and type of reconstruction planned [9]. Performing
an oncoplastic mastectomy is a much more difficult skill to ac-
quire than many assume; it is the basis of any good reconstruc-
tion and inadequately performed, and it is also the basis of most
early complications [10]. Correctly applied, the idealmastectomy
and immediate reconstruction has enabled a dramatic improve-
ment in quality of outcome and crucial to this is the concept that
the reconstruction itself needs to be seen as an integral part of
mastectomy planning. There are now very few contraindiactions
for immediate breast reconstruction in women who wish one,
with delayed reconstruction often being recommended for logis-
tical reasons or because of dogmatic and out-dated approaches to
managing the challenges posed by post-mastectomy
radiotherapy. Reconstruction options need to be considered early,
whether they be immediate or delayed, and surgery planned ap-
propriately and considerately from the start.
As with all oncoplastic surgery, mastectomy should aim to
perform as complete an oncological operation as possible.
However, maintaining the footprint of the breast (in terms of
medial, lateral, superior and inferior levels of dissection) along
with healthy mastectomy flaps is essential. When applicable, the
use of inframammary mastectomy with implant reconstruction
has major aesthetic and safety advantages [10]. Similarly, the
vertical mastectomy techniques, with or without nipple preserva-
tion can be ideal for autologous free flap reconstruction allowing
adequate access for microsurgery whilst maintaining an optimum
skin envelope. Limiting dissection to the breast footprint maxi-
mises vascular and some nerve supply to the breast skin and
minimises the required shaping of a flap reconstruction. Nipple
preservation is now considered for all mastectomy and immediate
reconstruction cases where oncologically appropriate and confers
significant psychosexual benefits [11, 12].
Oncoplastic Breast Conservation Surgery
Oncoplastic breast surgery aims to achieve good aesthetic out-
comes for women with breast cancers who would have unac-
ceptable outcomes with other BCS techniques, and in addi-
tion, enable breast-conserving surgery for larger breast can-
cers. Thus, many women who are treated by oncoplastic
breast surgery would otherwise have had a poor aesthetic out-
come from standard techniques of BCS or have been recom-
mended mastectomy. For many women oncoplastic breast
conserving surgery offers the best, simplest, lowest risk, and
sometimes only option for a good aesthetic and practical out-
come of breast cancer surgery.
An oncoplastic procedure aims to minimise cosmetic det-
riment to the breast by eliminating surgical cavities that will
then create distortion, hence, the terms parenchymal redistri-
bution or parenchymal replacement have been used. Our own
term, therapeutic mammaplasty, covers all forms of reduction
and mastopexy techniques, but in practice it can be easier to
consider these separately. Therefore, broadly speaking, breast-
conserving surgical techniques fall into four main categories:
○ Simple wide local excision
○ Therapeutic breast reduction
○ Therapeutic mastopexy
○ Volume replacement.
The role of these individual techniques in breasts of differ-
ent sizes is illustrated in Fig. 1.
Poor cosmetic outcome after simple wide local excision is
perhaps best predicted by the percentage of breast tissue being
removed and the location of the breast cancer although many
factors contribute. We have previously correlated the percentage
of breast tissue removed with patient satisfaction in a study
performed on women who did not have oncoplastic breast-
conserving surgery and have shown that depending on tumour
location, percentage excisions over 5–15 % are generally asso-
ciated with an unsatisfactory outcome if oncoplastic surgery is
not used [13]. Nowadays, although we would consider that all
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breast surgery should be oncoplastic, there are simple and com-
plex forms of oncoplastic surgery.
For those whose practice includes screen-detected disease,
there may be many indications to keep the surgery very sim-
ple, with minimum undermining of surrounding tissue and
closure of defect. The main oncoplastic requirement here
would be thoughtful incision planning, an understanding of
how breast deformity occurs in order to avoid it and careful
tissue handling. Any oncological cavity within the breast will
collapse and pull both parenchyma and skin towards the cav-
ity. Any skin excision or even incision will contract and create
some distortion. Central, medial cavities have relatively less
laxity and volume so they create more deformity. For exam-
ple, a transverse skin incision, or even worse excision, in the
inferior pole of the breast will pull down the nipple, create
breast ‘beaking’ and poor cosmetic outcomes. By orienting
the incision vertically, the natural lateral laxity of the breast
is used to fill the defect and the nipple position is maintained.
Scars around the areola and at the lateral or inferior breast
crease can be employed in suitable cases to avoid scar visibil-
ity. The use of skin undermining with simple wide local exci-
sion can allow greater parenchymal mobility when the tumour
defect does not easily collapse. However, extensive skin or
parenchymal undermining are often more disruptive and at
times unpredictable compared to a formal oncoplastic proce-
dure as described below. Skin undermining by itself is more
acceptable but if combined with parenchymal undermining
can create significant disruption, fat necrosis and deformity.
For women with large breasts, particularly those with mor-
bidity associated with breast size, bilateral breast reduction
should, in our opinion, always be offered when breast reduc-
tion skills are available and of a high standard. This is a good
option for any such woman wishing or accepting of a reduc-
tion, with any cancer size deemed suitable for breast conserva-
tion including those with very small cancers. Breast reduction
can reduce the additional morbidity from radiotherapy, as well
as achieve a quality of life benefit [14–19]. Breast reduction
also reduces risk of subsequent breast cancer [20]. For those
with larger cancers, a significant reduction can enable breast
conservation and be a particularly attractive option when com-
pared to mastectomy and reconstruction in such cases. In this
category of procedure therefore, women are undergoing a sig-
nificant reduction in overall breast size with a large volume of
normal breast tissue being removed in addition to the wide
local excision. The breast shape is usually maintained by cre-
ating secondary pedicles, in addition to the nipple pedicle
[5, 21]. There are, however, many ways of achieving an ac-
ceptable breast shape, and not every large-breasted woman
with breast cancer is a ideal candidate for a standard technique
of breast reduction. In such high risk cases, simplified forms
of breast reduction can safely achieve the same aims if a
woman is accepting of the associated scarring, and breast
Fig. 1 The graph illustrates the role of the four main techniques in oncoplastic breast-conserving surgery according to breast size (volume and bra size),
tumour size and estimated percentage of breast volume that would be removed as a wide local excision
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reduction in high risk cases becomes particularly simple if a
woman is accepting of having her nipples removed as part of
the resection [22]. These techniques include standard vertical
or Wise pattern reductions but without any nipple or paren-
chymal pedicles at all. They are suitable for cancers that lie
within these excision sites, and as they have no skin or paren-
chymal undermining or any pedicles are very safe and effec-
tive. Even simpler are the transverse ellipse ‘Melon slice’
excisions that may or may not excise the nipple but retain
enough breast tissue to achieve an acceptable breast mound
and shape.
For women with ptotic breasts who do not necessarily wish
a breast reduction, but are accepting of an alteration in breast
shape, bilateral therapeutic mastopexy is often the procedure
of choice. The principle here is that the only breast volume
reduction is the wide local excision itself. Hence, there is
usually only a small overall reduction in breast volume but a
variable reduction in the skin envelope, with the procedure
being more akin to a mastopexy than a reduction [23]. An
improved breast aesthetic may be the additional benefit.
There are a wide variety of techniques described that would
fulfil the objectives of this category of procedure, such as a
tennis racket [8], Benelli [24] or batwing mammaplasty [25].
Our preference would be to use a vertical scar mastopexy and
whole or hemi-breast rotations [23]. In each of these operative
procedures, nipple position and breast shape are altered and
the skin envelope is reduced to a varying degree. In some
cases, a woman may be accepting of having just the affected
breast adjusted and no symmetrising procedure. This is often
the best option when the breast shape is only being altered to a
small degree, one of the principles of oncoplastic surgery be-
ing that preserving breast shape and avoiding deformity
trumps overall symmetry as a priority outcome.
The use of this range of therapeutic mammaplasty tech-
niques is dependent on experience in both planning and exe-
cution of the techniques, and it is obviously vital that a sur-
geon gets minimal complications with standard mammoplasty
techniques before applying them to a cancer setting. It is very
possible to minimise complications with careful planning and
patient selection, avoiding tension in the skin closure and
careful dissection of the parenchymal pedicles with a good
understanding of vascularity to avoid fat necrosis and infec-
tions. When the skills are not available, it will be better to use
alternative simpler techniques with direct access to the cancer.
For women with small or non-ptotic breasts, breast form is
usually best maintained by combining the wide local excision
with volume replacement. The LICAP, MICAP and AICAP
(lateral, medial and anterior intercostal artery perforators)
flaps along with the LTAP (lateral thoracic artery perforator)
flap provide versatile local means of volume replacement with
acceptable donor site scarring. Although the most commonly
used LICAP flap is primarily suitable for lateral-based tu-
mours, in our opinion, there are very few cases with this breast
morphology regardless of tumour location that are not suitable
for a local perforator flap [7, 26, 27]. TheMICAP and AICAP
(medial and anterior intercostal artery perforator) flaps are
used for more medially based tumours. In those requiring a
larger volume flap or needing even greater reach, a TAP
(thoracodorsal artery perforator) flap may occasionally be
used. Other methods of volume replacement include the
latissimus dorsi miniflap, the omental flap, upper abdominal
advancement flaps, immediate fat grafting and free flap
techniques such as the TUG (transverse upper gracillis)
flap [28–32].
In summary therefore, a sensible approach is to keep it
simple where possible, particularly in those women with very
small cancers. Breast reduction can and should be offered to
all women with breast cancer and very large breasts.
Therapeutic breast reduction and therapeutic mastopexy (col-
lectively termed therapeutic mammaplasty) both give the op-
tion of maintaining a good breast shape and symmetry in the
range of breast size that we most commonly encounter.
Volume replacement with a local perforator flap is usually
the best option for small, non-ptotic breasts. With appropriate
minor modification, the four categories of procedure de-
scribed are each capable of managing a wide local excision
defect in any part of the breast. Importantly, oncoplastic sur-
gery caters for the full range of breast size and shape, not just
the larger breast. It allows for generous margins of excision,
which translate into low rates of margin involvement and sec-
ond therapeutic procedures [23]. Oncoplastic surgery would
almost always be performed at one operation with simulta-
neous symmetrising reduction/mastopexy or volume replace-
ment as appropriate to the category of technique being used.
There is rarely any benefit in delaying a symmetrising proce-
dure if one is desired. Delayed symmetrisation is not easier
and not more predictable, and it obviously has the potential to
leave women with significant asymmetry for a variable period
of time. In addition, delaying volume replacement makes the
procedure more difficult and more likely to require skin-
bearing flaps.
In general, when different options are available, the sim-
plest is preferred. Many women are accepting of small inden-
tations and asymmetries that surgeons would not be ‘proud
of’, and the primary focus and aim should always be to
achieve a successful oncological outcome and not necessarily
a ‘perfect’ breast. However, oncoplastic surgery allows appro-
priate cancer surgery to be combined with an acceptable aes-
thetic outcome, in some cases even an enhanced aesthetic
outcome.
In some situations, oncoplastic breast-conserving surgery
allows women the choice of avoiding mastectomy. This may
not only be particularly relevant to those who would require
post-mastectomy radiotherapy but also to those who require
axillary node clearance and those with morbidities and risk
factors for bigger surgery; all of which would be potential
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exclusion criteria or high risk factors for immediate breast
reconstruction [23, 33, 34].
Oncocosmetic Surgery
In all published series of breast-conserving surgery, aesthetic
outcome is reported in terms of the degree to which the out-
come is worse than the starting point. The perceived pinnacle
of aesthetic outcome is therefore the maintenance of existing
breast form or it being slightly worse, and these two categories
are usually combined in reports and achieved in approximate-
ly 60–85% of BCS cases for small cancers and approximately
55–70% ofmastectomywith reconstruction cases. A question
that is not often asked before breast cancer surgery is what a
woman thinks of her breast size and shape before surgery. If
the answer is negative, then maintaining breast form may not
be as ideal a result as the surgeon imagines. Such cases require
additional consideration, and the surgery that should be con-
sidered may fall into the controversial category of
oncocosmetic.
Although still debatable for many, the use of breast reduc-
tion for those who desire smaller breasts when being treated
for cancer is in our opinion easy to support. In the case of large
breast size and therapeutic reduction mammaplasty, it is easy
to imagine how a woman may desire a reduced breast size,
how this may lend itself to a wide local excision and how she
may positively perceive the outcome of her surgery. In many
cases, the reduction has enabled breast conservation as an
option. However, in other cases, for example a 10-mm cancer,
the reduction is performed for quality of life and cosmetic
benefit, as well as perhaps to avoid the potential morbidity
of radiotherapy.
For smaller breasts, breast conservation can maintain aes-
thetic appearance but rarely improves it. For those with ptosis,
a therapeutic mastopexy as described above may achieve an
optimised aesthetic for some. In reality, for most cases, it will
be used tominimise cosmetic deformity, which smaller breasts
are more susceptible to.
For others, a larger breast size may be the desire, and for
such women a mastectomy and augmented reconstruction
with contralateral augmentation, or bilateral mastectomy and
augmented reconstruction may be an option to consider.
Adjustment in overall breast size is a relatively frequent out-
come in bilateral mastectomy and breast reconstruction, and
achieving positive aesthetic outcomes rather than just main-
taining breast form or avoiding deformity should be within the
skill set of an oncoplastic surgeon. This discussion may raise
eyebrows for some, and it would be important to appreciate
that oncocosmetic surgery would only be appropriate for high-
ly selected cases and, in addition, experience in pure cosmetic
breast surgery would be essential for those who would prac-
tice it. However, as standards of aesthetic outcome of breast
cancer surgery have been raised, there is a greater realisation
of the importance of aesthetic outcome for some women and a
greater understanding of the effect of breast cancer surgery
and adjuvant treatments on body image and psychosocial out-
comes [35, 36]. Importantly, women with breast cancer never
wanted the surgery required to remove their disease. The
oncoplastic surgery that they may choose to correct their ap-
pearance as a result of this may have the option of not just
restoring original form to a varying degree but may, with little
or no extra cost, be able to offer a more desirable outcome.
Both patient and surgeon should feel this is a worthwhile
endeavour.
Conclusions
The principles of oncoplastic surgery are applicable to all
breast cancer surgery, although the options it can offer will
have much more relevance to some women than others. The
primary aim is always disease eradication, but the physical
effects of this can and should be minimised. A range of tech-
niques is possible spanning from very simple and functional,
to complex and cosmetic, but women who may benefit can
only do so if it is offered. Much of what is discussed in this
article reflects an individualised care to breast cancer surgery,
far removed from the one of two options approach of old.
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